Influenza A (H1N1) 2009 Monovalent Vaccine FDA Approval History
FDA Approved: Yes (First approved September 15, 2009)
Brand name: Influenza A (H1N1) 2009 Monovalent Vaccine
Generic name: H1N1 influenza virus vaccine
Company: CSL Limited; Novartis Vaccines and Diagnostics Limited; Sanofi Pasteur, Inc.; MedImmune LLC
Treatment for: Influenza Prophylaxis
Influenza A (H1N1) 2009 Monovalent Vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 6 months of age and older against influenza disease caused by pandemic (H1N1) 2009 virus.
Development timeline for Influenza A (H1N1) 2009 Monovalent Vaccine
| Date | Article |
|---|---|
| Nov 13, 2009 | Approval FDA Expands Approved Use of H1N1 Vaccines to Include Infants and Children |
| Sep 16, 2009 | Approval FDA Approves Vaccines for 2009 H1N1 Influenza Virus |
See also
Influenza A (H1N1) 2009 Monovalent Vaccine (H1N1 influenza virus vaccine) Consumer information
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
